{"version":"1.0","type":"link","title":"Auranofin, identified by FDA-approved drug library screening, inhibits HBs antigen secretion via lysosomal damage.","author_name":"Shimoda A 외","author_url":"https://prs-insight.online/author/Shimoda%20A","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/111418","thumbnail_width":1200,"thumbnail_height":630}